+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Pathology Market, by Product, Type, by Application, by End-User, by Region ; Trend Analysis, Competitive Market Share & Forecast, 2016-26

  • ID: 5024900
  • Report
  • April 2020
  • Region: Global
  • 177 pages
  • Blueweave Consulting & Research Pvt Ltd

FEATURED COMPANIES

  • 3DHISTECH
  • Danaher
  • Huron Digital Pathology
  • Leica Biosystems
  • Olympus Corporation
  • Ventana Medical Systems
The Global Digital Pathology Market reached USD 0.52 Billion in 2019 and projected to witness market size of USD 1.06 Billion by 2026 with a significant CAGR of 12.6% during the forecast period 2020-2026. Rising demand for digital pathology in disease diagnosis, easy consultation, and the digitalization trend in the medical industry boost the growth of the digital pathology market.

The growing use of telepathology, especially in developing economies are expected to generate new opportunities in the market. Technological advancements such as computerization, digital imaging, multiple fiberoptic communications, and robotic light microscopy are some of the major factors leading to the adoption of digital pathology.

Moreover, the introduction of cloud-based technology allowing the storage of digital slides along with secure access to pathologists anticipated to serve as a prospective growth driver for the market. The increasing government attention to implement advanced systems for improved efficiency and quick response is a contributing factor. Combined with these factors, the expanding patient pool, delays in radiography diagnostics owing to high waiting time are expected to provide a favorable environment for the adoption of digital pathology systems over the forecast period.

Artificial Intelligence with digital pathology stimulate the market with significant growth during the forecast period

Digital pathology systems are gaining popularity among pathologists owing to its operational efficiency and increasing need for integrated healthcare facilities. A combination of Artificial Intelligence (AI) technologies with digital pathology is a potential growth factor. Investors are ready to capitalize hugely in start-ups attempting to adopt artificial intelligence. Technology experts claim that machine learning and other sophisticated technologies can assist pathologists, making them more detailed in their analysis. Digital pathology market trends such as the integration of AI into digital pathology systems is expected to influence market growth. The adoption of AI in digital pathology offers efficient image recognition and automated diagnostic capabilities. Vendors are emphasizing on developing AI-powered software platforms to extend applications in digital pathology workflows such as automation in result interpretations, image analytics, and decision making. Automated applications will assist to overcome the challenges associated with the lack of trained professionals. To fulfill this growing demand, vendors are concentrating on the continuous development of AI platforms and applications by strategic initiatives.

North American regional segment expected to witness lucrative growth in global Digital Pathology market

North America is anticipated to hold the largest share in the global digital pathology market owing to accessibility of expertise, well-developed healthcare infrastructure, and increasing emphasis on digitization of diagnostic procedures. The technological advancements by leading market players are anticipated to augment the adoption of digital pathology systems in North America during the forecast period. Further, the increasing trends of machine learning and artificial intelligence in the region expected to drive the implementation of the global digital pathology market. Factors such as accessibility of expertise, well-developed healthcare infrastructure, and increasing focus on digitization of diagnostic procedures are contributing to the growth of the digital pathology in the region.

The device product segment is anticipated to dominate the digital pathology market

Based on the product, the device segment is expected to dominate the market as the devices can perform repeated data analysis across experiments and produce high-resolution images. Moreover, the rising use of scanners in pathology labs and increasing R&D related to applications such as slide managers is expected to boost the adoption of this technology during the forecast period. Growing demand for online storage system is further fueling the growth. The benefits such as improved productivity, cost reduction, and better patient outcome along with data reliability and Image Lifecycle Management (ILM) are projected to drive the market.


This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3DHISTECH
  • Danaher
  • Huron Digital Pathology
  • Leica Biosystems
  • Olympus Corporation
  • Ventana Medical Systems
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Research Methodology
2.1. Qualitative Research
2.1.1.Primary & Secondary Sources
2.2. Quantitative Research
2.2.1.Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.3.1.Secondary Research
2.3.2.Primary Research
2.4. Breakdown of Primary Research Respondents
2.5. Market Size Estimation
2.6. Assumption For The Study
2.7. Market Breakdown & Data Triangulation

3. Executive Summary

4. Global Digital Pathology Insights
4.1. DROC Analysis
4.1.1.Growth Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
4.2. Technological Landscape/Recent Developments
4.3. Regulatory Framework
4.4. Company Market Share Analysis,2019
4.5. Porter’s Five Forces Analysis
4.5.1.Bargaining Power of Suppliers
4.5.2.Bargaining Power of Buyers
4.5.3.Threat of New Entrants
4.5.4.Threat of Substitutes
4.5.5.Intensity of Rivalry

5. Global Digital Pathology Market Overview
5.1. Market Size & Forecast By Value, 2016-2026
5.1.1.By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.1.1. Software
5.2.1.2. Device
5.2.1.3. Communication Systems
5.2.1.4. Storage Systems
5.2.2. By Type
5.2.2.1. Human Pathology
5.2.2.2. Veterinary Pathology
5.2.3. By Application
5.2.3.1. Teleconsultation
5.2.3.2. Disease Diagnosis
5.2.3.3. Drug Discovery
5.2.3.4. Training and Education
5.2.3.5. Others
5.2.4. By End-User
5.2.4.1. Pharmaceutical & Biotechnology Companies
5.2.4.2. Hospitals and Reference Laboratories
5.2.4.3. Academic & Research Institutes
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific
5.2.5.4. Latin America
5.2.5.5. Middle East & Africa

6. North America Digital Pathology Market
6.1. Market Size & Forecast By Value, 2016-2026
6.1.1.By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1.By Product
6.2.2.By Type
6.2.3.By Application
6.2.4.By End-User
6.2.5.By Country
6.2.5.1. United States
6.2.5.2. Canada

7. Europe Digital Pathology Market
7.1. Market Size & Forecast By Value, 2016-2026
7.1.1.By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1.By Product
7.2.2.By Type
7.2.3.By Application
7.2.4.By End-User
7.2.5.By Country
7.2.5.1. Germany
7.2.5.2. United Kingdom
7.2.5.3. France
7.2.5.4. Italy
7.2.5.5. Spain
7.2.5.6. Rest of Europe

8. Asia Pacific Digital Pathology Market
8.1. Market Size & Forecast By Value, 2016-2026
8.1.1.By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1.By Product
8.2.2.By Type
8.2.3.By Application
8.2.4.By End-User
8.2.5.By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. South Korea
8.2.5.5. Rest of Asia Pacific

9. Latin America Digital Pathology Market
9.1. Market Size & Forecast By Value, 2016-2026
9.1.1.By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1.By Product
9.2.2.By Type
9.2.3.By Application
9.2.4.By End-User
9.2.5.By Country
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Argentina
9.2.5.4. Rest of Latin America

10. Middle East & Africa Digital Pathology Market
10.1. Market Size & Forecast By Value, 2016-2026
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Type
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. UAE
10.2.5.3. South Africa
10.2.5.4. Rest of Middle East and Africa

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, and Contact Address)*
11.1. Leica Biosystems
11.2. Ventana Medical Systems
11.3. Hamamatsu Photonics
11.4. 3DHISTECH
11.5. Koninklijke Philips
11.6. Roche
11.7. Apollo Enterprise Imaging
11.8. XIFIN
11.9. Huron Digital Pathology
11.10. Visiopharm
11.11. Corista
11.12. Indica Labs
11.13. Objective Pathology Services
11.14. Olympus Corporation
11.15. Mikroscan Technologies
11.16. Digipath, Inc.
11.17. TRIBVN Healthcare
11.18. Danaher
11.19. Nikon Corporation
11.20. Other Prominent Players
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Leica Biosystems
  • Ventana Medical Systems
  • Hamamatsu Photonics
  • 3DHISTECH
  • Koninklijke Philips
  • Roche
  • Apollo Enterprise Imaging
  • XIFIN
  • Huron Digital Pathology
  • Visiopharm
  • Corista
  • Indica Labs
  • Objective Pathology Services
  • Olympus Corporation
  • Mikroscan Technologies
  • Digipath Inc.
  • TRIBVN Healthcare
  • Danaher
  • Nikon Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll